Ototoxic drugs and noise.
Drugs that produce tinnitus can be subdivided into those which produce temporary or permanent hearing loss and those which apparently do not cause any hearing loss. The tinnitus occurring with drugs of the first group is probably secondary to the hearing loss. However, most of the drugs that produce tinnitus without an accompanying hearing loss probably do so because of their effect on biogenic amines in the central nervous system and/or as an extension of their proconvulsant side-effects. A pre-existing cochlear impairment is the underlying factor in most patients who experience tinnitus. Not only can ototoxic drugs or high levels of noise produce cochlear impairment but the interaction of the two can place humans in more jeopardy than when exposed to either agent alone. Chloramphenicol has little ototoxic potential when administered systemically in humans. However, our studies show that when chloramphenicol is combined with noise exposure in rats, considerably more cochlear damage results than from the noise alone (chloramphenicol alone does no produce any cochlear damage). We are presently conducting more detailed studies of this ototoxic interaction to determine whether it occurs with other antibiotics (such as erythromycin) which are also commonly considered to have minimal ototoxicity.
D000161:Acoustic Stimulation; D000818:Animals; D002490:Central Nervous System / Q000187:drug effects; D002701:Chloramphenicol / Q000009:adverse effects; D003051:Cochlea / Q000187:drug effects / Q000503:physiopathology / Q000648:ultrastructure; D003055:Cochlear Microphonic Potentials; D064420:Drug-Related Side Effects and Adverse Reactions; D005260:Female; D006311:Hearing Disorders / Q000139:chemically induced / Q000503:physiopathology; D006317:Hearing Loss, Noise-Induced / Q000150:complications / Q000503:physiopathology; D006801:Humans; D008297:Male; D004364:Pharmaceutical Preparations / Q000145:classification; D051381:Rats; D012640:Seizures / Q000503:physiopathology; D014012:Tinnitus / Q000139:chemically induced*
D004364:Pharmaceutical Preparations; D002701:Chloramphenicol